Allergan Aesthetics received FDA approval for SKINVIVE by JUVÉDERM for improvement of neck appearance. The approval expands the indication beyond the product's original clearance for chin and jawline contouring, opening a new treatment area for practices already stocking the product.
Allergan Wins FDA Nod for SKINVIVE by JUVÉDERM for Neck — New Indication, Familiar Economics
The FDA cleared SKINVIVE by JUVÉDERM for neck appearance improvement, expanding the HA filler's approved indications.

SKINVIVE's neck approval gives practices a new indication for an existing SKU without additional capital or training.
SKINVIVE is a smooth, cohesive HA filler designed for subtle volumization and skin quality improvement—distinct from traditional cross-linked fillers used for deeper lines. The neck indication is clinically sound: the area is thin-skinned, prone to laxity, and benefits from the product's mechanism. For practices, this is a straightforward expansion of an existing SKU; no new training or device acquisition required. Margin economics remain tied to Allergan's Allē rebate program and per-syringe cost, which practices should verify against their current loyalty terms.
Source: original report ↗
Frequently asked questions
What is SKINVIVE by JUVÉDERM used for now after FDA approval?
SKINVIVE is now FDA-cleared for improvement of neck appearance in addition to its original indications for chin and jawline contouring. It's a smooth, cohesive hyaluronic acid filler designed for subtle volumization and skin quality improvement in thin-skinned areas prone to laxity.
How is SKINVIVE different from traditional dermal fillers?
SKINVIVE is a smooth, cohesive HA filler optimized for subtle volumization and skin quality improvement, rather than deep line correction like traditional cross-linked fillers. This makes it better suited for delicate areas like the neck where a softer approach is needed.
Do medspa practices need new training or equipment to offer SKINVIVE for neck treatment?
No. Since SKINVIVE is an existing product with a new indication, practices already stocking it for chin and jawline work require no additional training or device acquisition to offer neck treatments.
How does the Allē rebate program affect SKINVIVE pricing for practices?
SKINVIVE margin economics are tied to Allergan's Allē rebate program and per-syringe cost. Practices should verify their current loyalty terms with Allergan to confirm rebate levels and ensure pricing aligns with their profit targets.
Why is the neck a good treatment area for SKINVIVE?
The neck is thin-skinned and prone to laxity, making it an ideal candidate for SKINVIVE's mechanism of subtle volumization and skin quality improvement rather than aggressive volumizing fillers.
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Seasoned Expat Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.